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Sorting  nexin,  SH3PX1,  has  been  associated  with  endocytosis  through  its 
interactions with key endocytic proteins involved in the processing of cell  surface 
receptors.    These  dramatic  cellular  effects,  largely  associated  with  the  tyrosine 
phosphorylation  of  SH3PX1,  have  elicited  interest  in  determining  the  molecular 
mechanisms underlying this phosphorylation event. 
The first major focus of these studies was to develop reagents that could be 
used to further characterize the role of SH3PX1 in endocytosis.  SH3PX1 has been 
identified  as  a  substrate  of  the  non-receptor  tyrosine  kinase,  activated  Cdc42-
associated kinase-2 (ACK2), and the resulting phosphorylation enhances degradation 
of the epidermal growth factor (EGF) receptor in cells.  In order to further characterize 
ACK2-catalyzed SH3PX1 phosphorylation, we have identified tyrosine 287 as a major 
site of phosphorylation by mass spectrometry.  Moreover, we have shown that the 
pyridopyrimidine, PD158780, is a potent inhibitor of ACK2 kinase activity in vitro 
(IC50  ~80  pM).    Together,  we  believe  that  phosphorylation-defective  mutants  of 
SH3PX1 and small molecule inhibitors of ACK2 kinase activity will help to further 
establish the roles of ACK2 and SH3PX1 in EGF receptor processing.  
The  second  aspect  of  these  studies  involved  the  identification  and 
characterization of novel tyrosine kinases that phosphorylate SH3PX1 in cells, namely 
focal  adhesion  kinase  (FAK)  and  Src.    Here,  we  show  that  FAK  and  Src  differ  
considerably from ACK2 in their abilities to phosphorylate SH3PX1.  For example, 
FAK  and  Src  are  more  effective  kinases  for  SH3PX1,  compared  to  ACK2.    In 
addition,  we  show  that  FAK  and  Src  are  able  to  phosphorylate  several  carboxyl-
terminal  truncation  mutants  of  SH3PX1  that  are  defective  for  ACK2-catalyzed 
phosphorylation, suggesting that FAK and Src bind to and phosphorylate different 
sites on SH3PX1.  This was further confirmed by mass spectrometry analysis which 
identified  residues  Y177,  Y239,  Y269,  Y294,  and  Y561,  as  Src-catalyzed 
phosphorylation sites, with Y239 as the major site.  Given the observed differences 
exhibited by FAK and Src, versus ACK2, in binding and phosphorylating SH3PX1, it 
now  seems  likely  that  this  sorting  nexin  may  be  responsible  for  translating  a 
complicated  array  of  regulatory  inputs  into  the  endocytosis  and  degradation  of 
membrane receptors.    
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